GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioasis Technologies Inc (FRA:107) » Definitions » Asset Turnover

Bioasis Technologies (FRA:107) Asset Turnover : 0.07 (As of Nov. 2022)


View and export this data going back to 2017. Start your Free Trial

What is Bioasis Technologies Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Bioasis Technologies's Revenue for the three months ended in Nov. 2022 was €0.11 Mil. Bioasis Technologies's Total Assets for the quarter that ended in Nov. 2022 was €1.53 Mil. Therefore, Bioasis Technologies's Asset Turnover for the quarter that ended in Nov. 2022 was 0.07.

Asset Turnover is linked to ROE % through Du Pont Formula. Bioasis Technologies's annualized ROE % for the quarter that ended in Nov. 2022 was 176.12%. It is also linked to ROA % through Du Pont Formula. Bioasis Technologies's annualized ROA % for the quarter that ended in Nov. 2022 was -187.97%.


Bioasis Technologies Asset Turnover Historical Data

The historical data trend for Bioasis Technologies's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioasis Technologies Asset Turnover Chart

Bioasis Technologies Annual Data
Trend Feb13 Feb14 Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.48 0.97 0.46 1.91 0.01

Bioasis Technologies Quarterly Data
Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 - - 0.07 0.07

Competitive Comparison of Bioasis Technologies's Asset Turnover

For the Biotechnology subindustry, Bioasis Technologies's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioasis Technologies's Asset Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bioasis Technologies's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Bioasis Technologies's Asset Turnover falls into.



Bioasis Technologies Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Bioasis Technologies's Asset Turnover for the fiscal year that ended in Feb. 2022 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Feb. 2022 )/( (Total Assets (A: Feb. 2021 )+Total Assets (A: Feb. 2022 ))/ count )
=0.026/( (2.134+1.571)/ 2 )
=0.026/1.8525
=0.01

Bioasis Technologies's Asset Turnover for the quarter that ended in Nov. 2022 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Nov. 2022 )/( (Total Assets (Q: Aug. 2022 )+Total Assets (Q: Nov. 2022 ))/ count )
=0.109/( (1.775+1.285)/ 2 )
=0.109/1.53
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Bioasis Technologies  (FRA:107) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Bioasis Technologies's annulized ROE % for the quarter that ended in Nov. 2022 is

ROE %**(Q: Nov. 2022 )
=Net Income/Total Stockholders Equity
=-2.876/-1.633
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-2.876 / 0.436)*(0.436 / 1.53)*(1.53/ -1.633)
=Net Margin %*Asset Turnover*Equity Multiplier
=-659.63 %*0.285*-0.9369
=ROA %*Equity Multiplier
=-187.97 %*-0.9369
=176.12 %

Note: The Net Income data used here is four times the quarterly (Nov. 2022) net income data. The Revenue data used here is four times the quarterly (Nov. 2022) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Bioasis Technologies's annulized ROA % for the quarter that ended in Nov. 2022 is

ROA %(Q: Nov. 2022 )
=Net Income/Total Assets
=-2.876/1.53
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-2.876 / 0.436)*(0.436 / 1.53)
=Net Margin %*Asset Turnover
=-659.63 %*0.285
=-187.97 %

Note: The Net Income data used here is four times the quarterly (Nov. 2022) net income data. The Revenue data used here is four times the quarterly (Nov. 2022) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Bioasis Technologies Asset Turnover Related Terms

Thank you for viewing the detailed overview of Bioasis Technologies's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioasis Technologies Business Description

Traded in Other Exchanges
N/A
Address
157 Church Street, 19th Floor, New Haven, CT, USA, 06510
Bioasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company has worked on a blood-brain barrier program and studies disorders in the brain. The company's xB3 program describes its proprietary carrier, for the delivery of therapeutics across the blood-brain barrier and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. The company's in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.

Bioasis Technologies Headlines

No Headlines